1. Home
  2. ANIX vs DOMA Comparison

ANIX vs DOMA Comparison

Compare ANIX & DOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • DOMA
  • Stock Information
  • Founded
  • ANIX 1982
  • DOMA 2018
  • Country
  • ANIX United States
  • DOMA United States
  • Employees
  • ANIX N/A
  • DOMA N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • DOMA Real Estate
  • Sector
  • ANIX Health Care
  • DOMA Finance
  • Exchange
  • ANIX Nasdaq
  • DOMA Nasdaq
  • Market Cap
  • ANIX 87.1M
  • DOMA 84.6M
  • IPO Year
  • ANIX 1987
  • DOMA N/A
  • Fundamental
  • Price
  • ANIX $2.91
  • DOMA $6.10
  • Analyst Decision
  • ANIX Strong Buy
  • DOMA Hold
  • Analyst Count
  • ANIX 1
  • DOMA 2
  • Target Price
  • ANIX $7.00
  • DOMA $6.29
  • AVG Volume (30 Days)
  • ANIX 70.4K
  • DOMA 12.5K
  • Earning Date
  • ANIX 09-04-2024
  • DOMA 08-06-2024
  • Dividend Yield
  • ANIX N/A
  • DOMA N/A
  • EPS Growth
  • ANIX N/A
  • DOMA N/A
  • EPS
  • ANIX N/A
  • DOMA N/A
  • Revenue
  • ANIX N/A
  • DOMA $315,772,000.00
  • Revenue This Year
  • ANIX N/A
  • DOMA N/A
  • Revenue Next Year
  • ANIX N/A
  • DOMA $14.56
  • P/E Ratio
  • ANIX N/A
  • DOMA N/A
  • Revenue Growth
  • ANIX N/A
  • DOMA N/A
  • 52 Week Low
  • ANIX $2.15
  • DOMA $3.86
  • 52 Week High
  • ANIX $5.13
  • DOMA $9.40
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 59.49
  • DOMA 64.82
  • Support Level
  • ANIX $2.16
  • DOMA $5.98
  • Resistance Level
  • ANIX $3.44
  • DOMA $6.06
  • Average True Range (ATR)
  • ANIX 0.21
  • DOMA 0.04
  • MACD
  • ANIX 0.10
  • DOMA 0.01
  • Stochastic Oscillator
  • ANIX 58.91
  • DOMA 100.00

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About DOMA Doma Holdings Inc.

Doma Holdings Inc is architecting the future of real estate transactions. The company uses machine intelligence and its patented technology solutions to transform residential real estate, making closings instant and affordable. The company operates through two complementary segments- Underwriting and Corporate and other. Majority revenue is generated from Underwriting segment. Underwriting segment reflects the results of its title insurance underwriting business, including policies referred through Direct Agents and Third-Party Agents channels. Corporate and Other segment includes operations related to the execution of the title, escrow and settlement services through Doma Enterprise channel.

Share on Social Networks: